Dogwood Therapeutics (DWTX) EPS (Basic) (2020 - 2026)
Dogwood Therapeutics (DWTX) posted quarterly EPS (Basic) of -$0.15 for Q1 2026, up 98.24% year-over-year from -$0.07 in Q1 2025, and up 80.43% quarter-over-quarter from -$0.76 in Q4 2025.
Dogwood Therapeutics (DWTX) EPS (Basic) (2020 - 2026) Analysis & Trends
Dogwood Therapeutics (DWTX) has reported EPS (Basic) for 7 consecutive years, with -$0.15 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 98.24% year-over-year to -$0.15; the TTM figure through Mar 2026 stood at -$0.84 (up 94.88% YoY), while the FY2025 annual figure was -$7.13, up 42.99% from the prior year.
- EPS (Basic) improved to -$0.15 in Q1 2026 per DWTX's latest filing, from -$0.76 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.15 in Q1 2026 and bottomed at -$11.89 in Q1 2022.
- Historically, EPS (Basic) has averaged -$4.36 across 5 years, with a median of -$2.05 in 2024.
- Annual changes were most pronounced in 2024 — EPS (Basic) plunged 445.97% — and 2026, when it jumped 98.24%.
- Dogwood Therapeutics' EPS (Basic) stood at -$4.62 in 2022, then surged by 68.19% to -$1.47 in 2023, then slumped by 445.97% to -$8.02 in 2024, then surged by 90.53% to -$0.76 in 2025, then jumped by 80.43% to -$0.15 in 2026.
- Business Quant data shows DWTX's EPS (Basic) at -$0.15 in Q1 2026, -$0.76 in Q4 2025, and -$8.2 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Dogwood Therapeutics | 84.98 Mn | 84.98 Mn | - | -0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | -0.76 |
| Sep 30, 2025 | -8.20 |
| Jun 30, 2025 | -1.99 |
| Mar 31, 2025 | -8.45 |
| Dec 31, 2024 | -8.02 |
| Sep 30, 2024 | -2.05 |
| Jun 30, 2024 | -1.15 |
| Mar 31, 2024 | -1.68 |
| Dec 31, 2023 | -1.47 |
| Sep 30, 2023 | -1.62 |
| Jun 30, 2023 | -1.96 |
| Mar 31, 2023 | -2.07 |
| Dec 31, 2022 | -4.62 |
| Sep 30, 2022 | -7.00 |
| Jun 30, 2022 | -11.01 |
| Mar 31, 2022 | -11.89 |
| Dec 31, 2021 | -13.54 |
| Sep 30, 2021 | -12.33 |
| Jun 30, 2021 | -12.85 |